在本文发表之后,有关读者提请编辑注意图所示的细胞侵袭和迁移测定数据。图6和图6所示的细胞增殖测定实验。2与不同作者在其他文章中以不同形式出现的数据惊人地相似;此外,在图中。2,对于“10mM二甲双胍”实验,某些神经胶质瘤细胞似乎与同一数据面板中包含的其他细胞非常相似。由于上述文章中的有争议的数据已经在其他地方发表,或者在提交给分子医学报告之前正在考虑发表,由于担心某些数据的真实性,编辑已经决定这篇论文应该从期刊上撤回。作者被要求解释这些担忧,但编辑部没有收到回复。编辑对读者造成的不便表示歉意。[分子医学报告20:887-894,2019年;DOI:10.3892/mmr.2019.10369]。
Following the publication of this paper, it was drawn to the Editors\' attention by a concerned reader that the cell invasion and migration assay data shown in Fig. 6 and the cell proliferation assay experiments shown in Fig. 2 were strikingly similar to data appearing in different form in other articles by different authors; furthermore, in Fig. 2, for the \'10 mM metformin\' experiment, certain of the glioma cells appeared to be strikingly similar to other cells contained within the same data panels. Owing to the fact that the contentious data in the above article had already been published elsewhere or were under consideration for publication prior to its submission to Molecular Medicine Reports, and owing to concerns with the authenticity of certain of the data, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 20: 887‑894, 2019; DOI: 10.3892/mmr.2019.10369].